Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …
Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …
Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data …
The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials. Verified Clinical Trials is a global research subject database registry. The registry is used by thousands of research sites across the US and in Europe to prevent many protocol deviations and most importantly, duplicate subjects in clinical …
Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data. The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening. What we have learned from experience and analytical data review over the …
Duplicate subjects exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subject or over enrollment. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global research subject database registry such as Verified Clinical Trials will help …
Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads. To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process. VCT verifies a research subject’s study history at the time of …
To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively. This is true for nearly all therapeutic indications and all phases of clinical trials research. Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue. The global research subject database registry VCT data over the …
Join us at #ASCP2019 in Phoenix this year Wed. May 29th at 1 PM as VCT hosts an expert panel on professional research subjects and duplicate subjects in CNS clinical trials. Duplicate subjects can ruin a trial, especially in the CNS space. Without a research subject database registry like Verified Clinical Trials it is nearly impossible …
Great article by John Carlos Diaz on the issue of hashtag#professionalresearchsubjects and hashtag#duplicatesubjects https://lnkd.in/eJrFDDF. Use of the Verified Clinical Trials (VCT) prevents this issue at the time of screening and protects throughout the entire study. Easy to implement and cost-effective. Contact VCT at info@verifiedclinicaltrials.com or call +1.516.998.7499
